IQVIA Holdings Inc. IQV is gaining from a massive addressable market, ... analytics-driven clinical development capabilities, ...

IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, ... PM Images. IQVIA Holdings (NYSE ... as it is one of the leading providers of advanced analytics, clinical research, ...

Contract research firm IQVIA Holdings raised its forecast for full-year profit on Monday, banking on strength in demand for its healthcare data and analytics services. Technological and analytical ...

RESEARCH TRIANGLE PARK, N.C., January 13, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a ...

IQVIA Holdings Inc IQV reported Q3 sales of $3.74 billion, up 4.9% Y/Y on a reported basis and 4.1% at constant currency (CC), missing the consensus of $3.78 billion. IQVIA reported Q3 adjusted ...

IQVIA Holdings cut its full-year profit forecast on Wednesday, citing weakness in demand for its analytics and medical technology solutions along with the impact of a stronger U.S. dollar.

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

Earnings per share were $1.97 on a GAAP diluted basis, with adjusted diluted earnings per share of $2.64. The company has now updated its guidance for the full year to be between $15.43 billion ...

IQVIA’s current ratio (a measure of liquidity) at the end of fourth-quarter 2024 was pegged at 0.84, lower than the industry’s 1.93. Despite a 3.7% rise from the preceding quarter, a current ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, ... Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise.